Climb Bio Inc (NASDAQ: CLYM) established initial surge of 5.92% at $3.22, before settling in for the price of $3.04 at the close. Taking a more long-term approach, CLYM posted a 52-week range of $2.35-$11.55.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 0.00%. Meanwhile, its Annual Earning per share during the time was -46.72%. This publicly-traded company’s shares outstanding now amounts to $67.22 million, simultaneously with a float of $51.48 million. The organization now has a market capitalization sitting at $216.46 million. At the time of writing, stock’s 50-day Moving Average stood at $4.54, while the 200-day Moving Average is $5.66.
Climb Bio Inc (CLYM) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Climb Bio Inc industry. Climb Bio Inc’s current insider ownership accounts for 23.41%, in contrast to 71.05% institutional ownership. According to the most recent insider trade that took place on Sep 20 ’24, this organization’s CHIEF ACCOUNTING OFFICER sold 1,191 shares at the rate of 8.18, making the entire transaction reach 9,741 in total value, affecting insider ownership by 7,564. Preceding that transaction, on Jul 22 ’24, Company’s EVP, R&D AND CSO sold 69,005 for 8.03, making the whole transaction’s value amount to 554,170. This particular insider is now the holder of 31,317 in total.
Climb Bio Inc (CLYM) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Climb Bio Inc (NASDAQ: CLYM) Trading Performance Indicators
Let’s observe the current performance indicators for Climb Bio Inc (CLYM). It’s Quick Ratio in the last reported quarter now stands at 57.73. The Stock has managed to achieve an average true range (ATR) of 0.32.
In the same vein, CLYM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.13.
Technical Analysis of Climb Bio Inc (CLYM)
Now, what If we examine the latest scores posted by [Climb Bio Inc, CLYM]. During the last 5-days, its volume was lower the volume of 0.46 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 36.48% While, its Average True Range was 0.29.
Raw Stochastic average of Climb Bio Inc (CLYM) in the period of the previous 100 days is set at 5.07%, which indicates a major fall in contrast to 22.22% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 89.18% that was higher than 86.65% volatility it exhibited in the past 100-days period.
